SCHEMBL25359178

SCHEMBL25359178

COc1c(Cl)nc(NC(=O)O)nc1-c1c(C)cccc1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 4/20 0.38
▸ TAS1R3 Q7RTX0 1/20 0.38
▸ TAS1R1 Q7RTX1 1/20 0.38
▸ TAS1R2 Q8TE23 1/20 0.38
▸ POLB P06746 3/20 0.36
▸ USP2 O75604 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24331124 0.79 HSP90AA1 (0.45) NPSR1ADORA2A
SCHEMBL29515175 0.79 HSP90AA1 (0.45) NPSR1ADORA2A
SCHEMBL26783458 0.78 MRGPRX4 (0.37) TAS1R3TAS1R1TAS1R2HSD17B10KMT2A
SCHEMBL24332218 0.77 TSHR (0.46) KMT2AKDM4EALDH1A1SMN1; SMN2MEN1
SCHEMBL29515246 0.77 TSHR (0.46) KMT2AKDM4EALDH1A1SMN1; SMN2MEN1
SCHEMBL25359894 0.75 SLC40A1 (0.47) KMT2AKDM4EALDH1A1SMN1; SMN2NPSR1
SCHEMBL29515216 0.75 SLC40A1 (0.47) KMT2AKDM4EALDH1A1SMN1; SMN2NPSR1
SCHEMBL29515197 0.71 LCK (0.32) POLBHSD17B10KDM4EALDH1A1
SCHEMBL24331097 0.71 LCK (0.32) POLBHSD17B10KDM4EALDH1A1
SCHEMBL24331363 0.69 LCK (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225762-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
Send feedback